Main outcome measures
The proportion of participants
requiring additional intravenous iron (500mg) to achieve and maintain
ferritin >30ug/L (diagnostic threshold for iron deficiency)
at 4 weeks post-infusion, and at 6 weeks, and 3-, 6- and 12-months
postpartum. Secondary endpoints included repeat infusion rate, iron
status, birth, and safety outcomes.